載入...
HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
The development of direct-acting antivirals (DAAs) has revolutionized the state-of-the art treatment of HCV infections, with sustained virologic response rates above 90%. However, viral variants harboring substitutions referred to as resistance-associated substitutions (RASs) may be present in basel...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020-06-01
|
| 叢編: | Frontiers in Cellular and Infection Microbiology |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/article/10.3389/fcimb.2020.00325/full |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|